BUSINESS COMBINATION AND DECONSOLIDATION OF SUBSIDIARY (Details Narrative) - USD ($)			1 Months Ended	6 Months Ended
	Jun. 05, 2020	May 14, 2019	Oct. 21, 2020	Jun. 30, 2021
Warrants issue purchase additional shares				4,143,706
Purchase price for the acquisition				$ 14,200,000
Closing Merger Consideration Shares, shares				6,909,091
Contingent Consideration Shares (Clawback Shares), shares				5,988,024
Aggregate amount				$ 20,000,000
Acquisition descriptions				The Company acquired Sera Labs through the issuance of shares of Common Stock of the Company with $1 million of cash consideration to be provided. The preliminary total purchase price was determined based on the following: i) $1 million of the Upfront Payment ii) Company’s closing price ($1.38) on October 2, 2020 for the closing merger consideration shares
Claw back shares		7,128,913
Upfront payment consideration		5,700,000
Acheivment shares		3,207,228
Earnout shares		8,018,071
Total potential shares to be issued				32,072,283
Upfront payment in cash			$ 1,000,000
Working capital				$ 4,000,000
Aggregate maximum milestones amount			$ 20,000,000
Potential shares to be issued			5,988,024
Fair value of contingent shares			$ 3,100,000
Cash consideration				$ 1,000,000
Earn out provisions and warrants				32,072,283
Note payable, principal amount				$ 2,000,000
Shares held in escrow	7,128,913			7,128,913
Issuable shares	11,225,299
Returnback shares	140,828
Gross proceed from warrant	$ 1,400,000
Warrant to purchase common stock	7,309,605
Purchase of common stock	708,467
Assigned back shares	310,821
Shares issue to holders	5,612,654
CHI [Member]
Total purchase price, shares			12,897,115
Convertible Note [Member]
Debt instrument converted amount, principal				$ 14,600,000